.
Phase 1
- Conditions
- .Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2016-001603-23-FR
- Lead Sponsor
- CHU de Clermont-Ferrand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .
- Secondary Outcome Measures
Name Time Method Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .